Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

YM merges with Cytopia in $Cdn12mm deal

Executive Summary

YM Biosciences (therapeutics for cancer and pain) has agreed to merge with Australia's Cytopia (oncology focused, with other treatments for cardiovascular, autoimmune, and inflammatory conditions). YM will issue one of its common shares for every 11.737 Cytopia shares, or an aggregate of 7.2mm shares valued at $Cdn12mm ($11.1mm). The per share ratio of $Cdn0.17 represents a 55% premium.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies